Sanofi Consumer Healthcare India Ltd
SANOFICONRSanofi Consumer Healthcare India Ltd
SANOFICONR
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 54.08 | 6,613.31 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.49 | 6.67 | 0.52% |
Forecast & Ratings
Detailed Forecast from 1 analyst
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Sanofi Consumer Healthcare India Ltd produces and markets a wide range of consumer healthcare products, including pharmaceuticals and nutritional products.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2023 | TTM | ||
|---|---|---|---|---|
| Total Revenue | 0.00 | 755.10 | ||
Raw Materials | 0.00 | 468.20 | ||
| Power & Fuel Cost | 0.00 | |||
| Employee Cost | 0.00 | |||
| Selling & Administrative Expenses | 0.30 | |||
| Operating & Other expenses | 0.00 | |||
EBITDA | -0.30 | 286.90 | ||
| Depreciation/Amortization | 0.00 | 4.20 | ||
| PBIT | -0.30 | 282.70 | ||
| Interest & Other Items | 0.00 | 3.50 | ||
| PBT | -0.30 | 279.20 | ||
| Taxes & Other Items | 0.00 | 71.30 | ||
| Net Income | -0.30 | 207.90 | ||
| EPS | -1.50 | 1,039.50 | ||
| DPS | 0.00 | 0.00 | ||
| Payout ratio | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Sanofi Consumer Healthcare India Ltd | -37,475.43 | 6,613.31 | — |
| Sun Pharmaceutical Industries Ltd | 46.13 | 6.58 | 0.73% |
| Cipla Ltd | 29.21 | 4.49 | 0.87% |
| Mankind Pharma Ltd | 62.91 | 12.57 | — |
Price Comparison
Compare SANOFICONR with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Jun 2024
Sep 2024
Oct 2024
Shareholding History
Mutual Funds Holding Trend
No mutual funds holding trends are available
Top 5 Mutual Funds holding Sanofi Consumer Healthcare India Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Nippon India Growth Fund - Growth Option - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.3901% | Percentage of the fund’s portfolio invested in the stock 0.46% | Change in the portfolio weight of the stock over the last 3 months 0.21% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 88/103 (+7) |
SBI FUNDS MANAGEMENT PVT LTD#SBI MF-SBI MAGNUM MIDCAP FUND DIRECT PL GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.2912% | Percentage of the fund’s portfolio invested in the stock 0.68% | Change in the portfolio weight of the stock over the last 3 months 0.50% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 71/82 (+1) |
Aditya Birla Sun Life Frontline Equity Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.1848% | Percentage of the fund’s portfolio invested in the stock 0.45% | Change in the portfolio weight of the stock over the last 3 months 0.08% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 56/96 (+20) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
SANOFICONR has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeSanofi Consumer Healthcare India announced that Surendra Agarwall, Whole-time Director and Chief Financial Officer, has tendered his resignation effective from the close of business hours of 31 December 2024 to pursue other opportunities outside of the Company.Powered by Capital Market - Live
Sanofi Consumer Healthcare India will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant